Abstract

Given the risk of cardiovascular complications in COVID-19, including exacerbation of pre-existing heart disease, acute myocardial injury, and drug-related cardiac arrhythmias, echocardiography (ECHO) is one of the main diagnostic methods for examining patients with suspected infection or confirmed disease. The article presents the main statements regarding transthoracic ECHO during a pandemic. The main issues related to the FOCUS ECHO are described, as it may play important diagnostic role in case of suspected myocarditis, which can be one of the manifestations of heart damage of coronavirus infection.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.